Milbank Quarterly

Papers
(The TQCC of Milbank Quarterly is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
Rapid Transition to Telehealth and the Digital Divide: Implications for Primary Care Access and Equity in a Post‐COVID Era151
US State Policies, Politics, and Life Expectancy123
COVID‐19 and Underinvestment in the Public Health Infrastructure of the United States112
International Collaboration to Ensure Equitable Access to Vaccines for COVID‐19: The ACT‐Accelerator and the COVAX Facility91
Situating the Continuum of Overdose Risk in the Social Determinants of Health: A New Conceptual Framework83
Rethinking Integrated Care: A Systematic Hermeneutic Review of the Literature on Integrated Care Strategies and Concepts73
Long COVID and Health Inequities: The Role of Primary Care66
The Impact of Choosing Wisely Interventions on Low‐Value Medical Services: A Systematic Review66
Life Satisfaction and Subsequent Physical, Behavioral, and Psychosocial Health in Older Adults62
Can Social Policies Improve Health? A Systematic Review and Meta‐Analysis of 38 Randomized Trials58
Dark Nudges and Sludge in Big Alcohol: Behavioral Economics, Cognitive Biases, and Alcohol Industry Corporate Social Responsibility52
A Commons for a Supply Chain in the Post‐COVID‐19 Era: The Case for a Reformed Strategic National Stockpile47
Measuring Community‐Engaged Research Contexts, Processes, and Outcomes: A Mapping Review38
Artificial Intelligence and Liability in Medicine: Balancing Safety and Innovation37
Approval of Cancer Drugs With Uncertain Therapeutic Value: A Comparison of Regulatory Decisions in Europe and the United States33
COVID‐19 and Underinvestment in the Health of the US Population25
The Role of Value‐Based Payment in Promoting Innovation to Address Social Risks: A Cross‐Sectional Study of Social Risk Screening by US Physicians25
COVID‐19: The Time for Collaboration Between Long‐Term Services and Supports, Health Care Systems, and Public Health Is Now25
Money Moves the Mare: The Response of Community‐Based Organizations to Health Care's Embrace of Social Determinants23
Population Health in the Time of COVID‐19: Confirmations and Revelations22
Savings or Selection? Initial Spending Reductions in the Medicare Shared Savings Program and Considerations for Reform21
US State Polarization, Policymaking Power, and Population Health20
State‐Level Transgender‐Specific Policies, Race/Ethnicity, and Use of Medical Gender Affirmation Services among Transgender and Other Gender‐Diverse People in the United States19
Weathering in Detroit: Place, Race, Ethnicity, and Poverty as Conceptually Fluctuating Social Constructs Shaping Variation in Allostatic Load18
Personalized Medicine, Disruptive Innovation, and “Trailblazer” Guidelines: Case Study and Theorization of an Unsuccessful Change Effort17
Ethical and Legal Implications of Remote Monitoring of Medical Devices17
“Super‐Utilizer” Interventions: What They Reveal About Evaluation Research, Wishful Thinking, and Health Equity16
Effects of the COVID‐19 Emergency and National Lockdown on Italian Citizens’ Economic Concerns, Government Trust, and Health Engagement: Evidence From a Two‐Wave Panel Study16
Medicare's Bundled Payment Initiatives for Hospital‐Initiated Episodes: Evidence and Evolution16
Conceptualizing the Mechanisms of Social Determinants of Health: A Heuristic Framework to Inform Future Directions for Mitigation15
Allocating a COVID‐19 Vaccine: Balancing National and International Responsibilities15
County‐Level Recreational Marijuana Policies and Local Policy Changes in Colorado and Washington State (2012‐2019)14
Population Health Innovations and Payment to Address Social Needs Among Patients and Communities With Diabetes14
Financing Approaches to Social Prescribing Programs in England and the United States14
Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing Regulation13
Social Prescribing in National Health Service Primary Care: What Are the Ethical Considerations?13
Population Health Science: Fulfilling the Mission of Public Health13
The Commercial Determinants of Three Contemporary National Crises: How Corporate Practices Intersect With the COVID‐19 Pandemic, Economic Downturn, and Racial Inequity13
The Structure and Financing of Health Care Systems Affected How Providers Coped With COVID‐1912
Leading Innovative Practice: Leadership Attributes in LEAP Practices12
Educational Inequalities in Hospital Use Among Older Adults in England, 2004‐201512
The Communication Infrastructure as a Social Determinant of Health: Implications for Health Policymaking and Practice11
Out‐of‐Network Air Ambulance Bills: Prevalence, Magnitude, and Policy Solutions11
Our Postpandemic World: What Will It Take to Build a Better Future for People and Planet?11
Power and Purchasing: Why Strategic Purchasing Fails11
Identifying Opportunities to Strengthen the Public Health Informatics Infrastructure: Exploring Hospitals’ Challenges with Data Exchange10
Midwifery and Birth Centers Under State Medicaid Programs: Current Limits to Beneficiary Access to a High‐Value Model of Care10
First Things First: How to Elicit the Initial Program Theory for a Realist Evaluation of Complex Integrated Care Programs10
Quality and Cost of Care by Hospital Teaching Status: What Are the Differences?9
Jail Health Care in the Southeastern United States From Entry to Release9
The Future of Social Determinants of Health: Looking Upstream to Structural Drivers9
Electronic Health Records as Biased Tools or Tools Against Bias: A Conceptual Model9
Fifty Years of Trust Research in Health Care: A Synthetic Review9
Participation, Pricing, and Enrollment in a Health Insurance “Public Option”: Evidence From Washington State's Cascade Care Program8
Patient Identification of Diagnostic Safety Blindspots and Participation in “Good Catches” Through Shared Visit Notes7
The Demise of Artificial Trans Fat: A History of a Public Health Achievement7
Evidence‐Based Message Strategies to Increase Public Support for State Investment in Early Childhood Education: Results from a Longitudinal Panel Experiment7
7
The Evolution of Supply and Demand in Markets for Generic Drugs7
7
Nurse Practitioner Scope‐of‐Practice Laws and Opioid Prescribing7
Upstream Policy Changes to Improve Population Health and Health Equity: A Priority Agenda7
Making Communities More Visible: Equity‐Centered Data to Achieve Health Equity6
6
Information From Same‐Race/Ethnicity Experts Online Does Not Increase Vaccine Interest or Intention to Vaccinate5
5
Reflections on the Five Laws of Integrating Medical and Social Services—21 Years Later5
5
Evidence on Scaling in Health and Social Care: An Umbrella Review5
Advancing Action on Health Equity Through a Sociolegal Model of Health5
Developing a Structure of Essential Services for a Child and Adolescent Mental Health System5
Assessment of Population‐Level Disadvantage Indices to Inform Equitable Health Policy5
The Perils of Medicalization for Population Health and Health Equity5
5
How Ethnic Minority Context Alters the Risk for Developing Mental Health Disorders and Psychological Distress for Latinx Young Adults5
Measuring the Trustworthiness of Health Care Organizations and Systems5
Redefining the “Public Option”: Lessons from Washington State and New Mexico5
0.018373012542725